Gayathri Viswanathan
Overview
Explore the profile of Gayathri Viswanathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
C Sekhar V, Gulia K, Deepti A, Baby Chakrapani P, Baby S, Viswanathan G
Mol Neurobiol
. 2023 Nov;
61(6):3296-3313.
PMID: 37987958
Therapeutic options to contain seizures, a transitional stage of many neuropathologies, are limited due to the blood-brain barrier (BBB). Herbal nanoparticle formulations can be employed to enhance seizure prognosis. Bacoside...
2.
Viswanathan G, Rajagopal S
Eur Heart J
. 2023 Feb;
44(14):1280-1282.
PMID: 36805649
No abstract available.
3.
Viswanathan G, Kirshner H, Nazo N, Ali S, Ganapathi A, Cumming I, et al.
Am J Respir Crit Care Med
. 2023 Feb;
207(10):1358-1375.
PMID: 36803741
Chronic thromboembolic pulmonary hypertension (CTEPH) is a sequela of acute pulmonary embolism (PE) in which the PE remodels into a chronic scar in the pulmonary arteries. This results in vascular...
4.
Ma Z, Viswanathan G, Sellig M, Jassal C, Choi I, Garikipati A, et al.
JACC Basic Transl Sci
. 2021 Dec;
6(11):854-869.
PMID: 34869949
Pulmonary arterial hypertension (PAH) is a disease of abnormal pulmonary vascular remodeling whose medical therapies are thought to primarily act as vasodilators but also may have effects on pulmonary vascular...
5.
Ajitha A, Kumar S, Viswanathan G, Baby S, Biju P
Comb Chem High Throughput Screen
. 2021 Feb;
25(10):1672-1681.
PMID: 33568028
Background: Over the last few decades, there has been a stupendous change in the area of drug delivery using particulate delivery systems, with increasing focus on nanoparticles in recent times....
6.
Smith J, Pack T, Inoue A, Lee C, Zheng K, Choi I, et al.
Science
. 2021 Jan;
371(6534).
PMID: 33479120
Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) are common drug targets and canonically couple to specific G protein subtypes and β-arrestin adaptor proteins. G protein-mediated signaling and β-arrestin-mediated signaling...
7.
Lee C, Viswanathan G, Choi I, Jassal C, Kohlmann T, Rajagopal S
Biomolecules
. 2020 Dec;
11(1).
PMID: 33374806
The vascular endothelium is the innermost layer of blood vessels and is a key regulator of vascular tone. Endothelial function is controlled by receptor signaling through G protein-coupled receptors, receptor...
8.
Dan V, Varghese T, Viswanathan G, Baby S
Curr Cancer Drug Targets
. 2019 Sep;
20(1):33-46.
PMID: 31560288
Targeted drug delivery systems gave newer dimensions for safer and more effective use of therapeutic drugs, thus helping in circumventing the issues of toxicity and unintended drug accumulation. These ongoing...
9.
Mamazhakypov A, Viswanathan G, Lawrie A, Schermuly R, Rajagopal S
Br J Pharmacol
. 2019 Aug;
178(1):72-89.
PMID: 31399998
Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary artery remodelling leading to increased right ventricular pressure overload, which results in right heart failure and premature death. Inflammation plays a...
10.
Viswanathan G, Dan V, Radhakrishnan N, Nair A, Nair A, Baby S
J Ethnopharmacol
. 2019 Mar;
236:474-483.
PMID: 30872170
Ethnopharmacological Relevance: Centella asiatica (CA) is a medicinal herb traditionally used as a brain tonic in Ayurvedic medicine. Various ethnomedical leads revealed the effective use of CA in the treatment...